Grünenthal Responsability Report 2025/2026

Responsibility at Grünenthal goes beyond policies and numbers. It is reflected in how we act every day – guided by our vision of a World Free of Pain and a clear ambition to create positive change over and above our core business. This report shows how our people bring this commitment to life, through real-world examples, authentic voices and tangible achievements from across Grünenthal.

As a research-driven pharmaceutical company with affiliates in 28 countries and products available in around 100 countries, we innovate to improve the lives of people affected by pain and adjacent diseases worldwide.

Grünenthal is externally recognised as an industry leader in environmental, social and governance (ESG) practices. We focus on what matters most across our entire value chain by prioritising topics with the greatest positive impact on patients, our people, and the planet.

These areas shape our Corporate Responsibility programme. Environmental stewardship, social equity, and ethical business conduct are embedded into how we set strategy, manage risks, and make decisions.

Through transparent reporting, independent ratings, and continuous improvement, responsibility at Grünenthal is both a measure of accountability and a driver of long-term value for all our stakeholders.